PASITHEA THERAPEUTICS CORP. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets
PASITHEA THERAPEUTICS CORP. (KTTA) had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets of $3.98 million as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less) › Business Combination, Recognized Asset Acquired, Asset
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets · last filed 2022-11-14
- 2022-09-30: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets $3.98M.
- 2022-06-30: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets $3.98M.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets |
|---|---|
| 2022-09-30 | $3.98M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $3.98M 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |